Federal grants to Inlighta Biosciences L.L.C.
Inlighta Biosciences L.L.C. in Marietta, Georgia received $3.9 million in federal grants from fiscal 2021 to 2025, across 5 awards. Its largest program was Cancer Detection and Diagnosis Research, with $2.0 million. In fiscal 2025 it was awarded $1.0 million.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$3.9 million
- Awards5
- Awarded in FY 2025$1.0 million
- Largest award$2.0 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 2 | $984,309 |
| FY 2022 | 1 | $954,220 |
| FY 2023 | 2 | $1.3 million |
| FY 2024 | 1 | -$316,028 |
| FY 2025 | 1 | $1.0 million |
Programs that fund Inlighta Biosciences L.L.C.
| Program | Awards | Amount |
|---|---|---|
| Cancer Detection and Diagnosis Research | 1 | $2.0 million |
| Allergy and Infectious Diseases Research | 1 | $1.0 million |
| Alcohol Research Programs | 1 | $344,538 |
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 1 | $323,743 |
| Cardiovascular Diseases Research | 1 | $298,840 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 5 | $3.9 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Non-invasive staging of metastasis by precision mri - project summary/abstract this sbir application will develop an improved contrast agent for precision staging through early and accurate detection of pancreatic ductal adenocarcinoma (PDAC) liver metastasis. We have created an innovative platform | Cancer Detection and Diagnosis Research | September 22, 2022 | $2.0 million |
| Precision mri with protein contrast agent for noninvasive detection of lung fibrosis - summary lung diseases, such as interstitial lung diseases, including idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), and acute viral infection, are major leading causes of death | Allergy and Infectious Diseases Research | August 25, 2025 | $1.0 million |
| Development of a novel mri contrast agent for early detection of alcoholic steatohepatitis | Alcohol Research Programs | August 30, 2021 | $345,070 |
| Design of calcium-sensing receptor targeted thera(g)nostic agents - summary calcium-sensing receptor (CASR), as one of the family c g-protein-coupled receptors (GPCRS), largely modulates extracellular CA2+ by triggering multiple intracellular signaling pathways. Casr is expressed in the kidneys, par | Diabetes, Digestive, and Kidney Diseases Extramural Research | August 30, 2024 | $323,743 |
| Precision mri with a novel protein contrast agent for early detection and staging of lung fibrosis - summary lung diseases, such as interstitial lung diseases including idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), and acute viral infection are major leading caus | Cardiovascular Diseases Research | September 15, 2023 | $298,840 |
Questions people ask
How much federal grant money does Inlighta Biosciences L.L.C. get?
$3.9 million in 5 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Inlighta Biosciences L.L.C. the most?
The Department of Health and Human Services, with $3.9 million in 5 awards.
What is Inlighta Biosciences L.L.C.'s largest federal grant?
$2.0 million under Cancer Detection and Diagnosis Research, with its first action in the period on September 22, 2022. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Inlighta Biosciences L.L.C.?
Its largest are Cancer Detection and Diagnosis Research, Allergy and Infectious Diseases Research and Alcohol Research Programs.
Other grant recipients in Marietta
- Department of Defense Georgia
- Ski Us, Inc.
- County of Cobb
- Chattahoochee Technical College
- Good Samaritan Health Center of Cobb, Inc.
- Moonlight Therapeutics, Inc.
- Life University, Inc.
- Proda Biotech L.L.C.
Largest federal grant recipients in Georgia · Federal grants in Georgia